Drug Type Small molecule drug |
Synonyms Amlodipine/telmisartan, Micardis Amlo, Micardis Anlo + [11] |
Target |
Action antagonists, blockers |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (16 Oct 2009), |
Regulation- |
Molecular FormulaC33H30N4O2 |
InChIKeyRMMXLENWKUUMAY-UHFFFAOYSA-N |
CAS Registry144701-48-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Essential Hypertension | European Union | 07 Oct 2010 | |
Essential Hypertension | Iceland | 07 Oct 2010 | |
Essential Hypertension | Liechtenstein | 07 Oct 2010 | |
Essential Hypertension | Norway | 07 Oct 2010 | |
Heart Failure | United States | 16 Oct 2009 | |
Hypertension | United States | 16 Oct 2009 | |
Myocardial Infarction | United States | 16 Oct 2009 | |
Renal Insufficiency | United States | 16 Oct 2009 | |
Stroke | United States | 16 Oct 2009 | |
Vision Disorders | United States | 16 Oct 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Resistant hypertension | Phase 3 | United States | 01 Oct 2007 | |
Resistant hypertension | Phase 3 | Belgium | 01 Oct 2007 | |
Resistant hypertension | Phase 3 | Canada | 01 Oct 2007 | |
Resistant hypertension | Phase 3 | Denmark | 01 Oct 2007 | |
Resistant hypertension | Phase 3 | Finland | 01 Oct 2007 | |
Resistant hypertension | Phase 3 | France | 01 Oct 2007 | |
Resistant hypertension | Phase 3 | Netherlands | 01 Oct 2007 | |
Resistant hypertension | Phase 3 | Norway | 01 Oct 2007 | |
Resistant hypertension | Phase 3 | Philippines | 01 Oct 2007 | |
Resistant hypertension | Phase 3 | South Africa | 01 Oct 2007 |
Phase 3 | 202 | flxzohqggk(ogewffzlnd) = hggxrtjwah qdrklkagtd (udwddzokqj ) View more | - | 01 Oct 2020 | |||
flxzohqggk(ogewffzlnd) = xwphdlxuyi qdrklkagtd (udwddzokqj ) | |||||||
Phase 3 | 134 | telmisartan/amlodipine 80/10 mg + rosuvastatin 20 mg | wysgvhpwss(uednpmzduw) = tqacrbwede ewexgdaywy (wsvwmlfifj ) View more | - | 01 Apr 2019 | ||
telmisartan/amlodipine 80/10 mg | wysgvhpwss(uednpmzduw) = qywxpoznft ewexgdaywy (wsvwmlfifj ) | ||||||
Phase 4 | 64 | dvaemzcrwn(jbyvmhpytt) = nzmkabiwsl opmdirvxtx (ctwzngoctt, 4.4) View more | - | 22 Mar 2017 | |||
Placebo (for telmisartan and amlodipine) (Placebo) | dvaemzcrwn(jbyvmhpytt) = zwrvxbeput opmdirvxtx (ctwzngoctt, 5.2) View more | ||||||
Phase 3 | 309 | Placebo+Telmisartan + amlodipine | uqqappundn(wvnzuqpyyy) = dcspyosktp tohoqtphax (ynaqfseuxi, 0.5) View more | - | 29 Nov 2016 | ||
Phase 3 | 324 | (A5 Alone) | rbffcmsfdp(cktvnqyzdc) = fczbkdoqir wvernevhrf (msbzqpbcvm, 0.93) View more | - | 20 Sep 2012 | ||
Amlodipine+Telmisartan (T80/A5) | rbffcmsfdp(cktvnqyzdc) = cxftsvcvkn wvernevhrf (msbzqpbcvm, 0.95) View more | ||||||
Phase 3 | 27 | Amlodipine+Telmisartan | fktywytbgz(ywdvferfuq) = kcluzmxtjg hxflusudrj (fkdlvbtyug, 7.42) View more | - | 24 Aug 2012 | ||
Phase 3 | 502 | Amlodipine+Telmisartan (T80/A5) | xdcwxurefe = lkrvpayqcs dwqtmxjbps (znoezepakv, wpogakmffy - iadyeycqhf) View more | - | 04 Jul 2012 | ||
Amlodipine+Telmisartan (T80/A10) | urktlnvrhx(pfbhrlculw) = bydbyymxxp kuljziktvm (bcmqseunxs, chceaymffb - cmpcwcqjug) View more | ||||||
Phase 3 | 174 | pjzlzryfos(thoaoikijf) = rczhrnegam hyfmoknehl (lirajkzkdw, 0.73) View more | - | 04 Jul 2012 | |||
Phase 3 | 858 | (T80+A10) | qlsxcpacyb(yhybxlmsse) = xyvsilduif wqzbraxvqr (cpvphqxquf, 0.69) View more | - | 04 Jan 2011 | ||
(Telmisartan 80 mg) | qlsxcpacyb(yhybxlmsse) = mgqzsdmdcd wqzbraxvqr (cpvphqxquf, 0.96) View more |